A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | AA | AB | AC | AD | AE | AF | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | COLLABORATOR CONTACT INFORMATION/PUBLIC DATABASE INFORMATION | CELL LINE CLINICAL FEATURES | DEMOGRAPHIC INFORMATION | CELL LINE GENOMIC INFORMATION | CELL LINE GROWTH AND FREEZING CONDITIONS | ||||||||||||||||||||||||||||
2 | Name of cell line | Collaborator Name | Institution (laboratory) | Email contact | Cell line availability | CCLE name | Dep Map ID | Cancer Type | Type of Melanoma | Tissue Origin of Cell line | Location of Primary Tumor | Stage of disease at tissue collection | Species | Gender | Age of diagnosis | Ethnicity | Oncogenic profile* | Oncogenic profile shared with tumor sample | Other mutations | Total # mutations | NGS used | Genomic references (PMID) | Genomic profiling | Comments | Mycoplasma tested/Result | Growth Properties | Culture Media | Culture Conditions | Doubling Time | Storage conditions | Freezing media | Culture/Other Comments | |
3 | MB2141 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | YES | not assigned | not assigned | Melanoma | Mucosal | subcutaneous metastasis | anorectal | Metastatic | Human | Female | 63 | Caucasian | EML4-ALK fusion | 29054983, 30185782 | See comments | Patient tumor has WES. PDX model has RNAseq. | Yes (Negative) | adherent | RPMI 1640, 10% FBS | Temperature: 37°C, 5% CO2 | 2 days | Liquid nitrogen | 90% FBS + 10% DMSO | ||||||
4 | MB3443 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | YES | not assigned | not assigned | Melanoma | Mucosal | subcutaneous neck metastais | Vulvovaginal | Metastatic | Human | Female | 63 | Caucasian | NRAS Q61H, TSC2 A583T, RICTOR D1432N, CDKN2A loss | 29054983, 30185782 | See comments | Patient tumor has WES, Foundation Medicine testing. PDX model has RNAseq. | Yes (Negative) | adherent | RPMI 1640, 10% FBS | Temperature: 37°C, 5% CO2 | 3 days | Liquid nitrogen | 90% FBS + 10% DMSO | ||||||
5 | MB4628 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | YES | N/A | N/A | Melanoma | Mucosal | Primary nasopharyngeal | nasopharyngeal | Human | Male | 85 | Caucasian | NRAS Q61R | RNAseq | Unpublished. | |||||||||||||||
6 | |||||||||||||||||||||||||||||||||
7 | |||||||||||||||||||||||||||||||||
8 | |||||||||||||||||||||||||||||||||
9 | |||||||||||||||||||||||||||||||||
10 | |||||||||||||||||||||||||||||||||
11 | COLLABORATOR CONTACT INFORMATION/PUBLIC DATABASE INFORMATION | PDX CLINICAL FEATURES | DEMOGRAPHIC INFORMATION | PDX MODEL GENOMIC INFORMATION | |||||||||||||||||||||||||||||
12 | Name of PDX Model | Collaborator Name | Institution (laboratory) | Email contact | PDX availability | CCLE name | Dep Map ID | Cancer Type | Type of Melanoma | Tissue Origin of PDX | Location of Primary Tumor | Stage of disease at tissue collection | Species | Gender | Age of diagnosis | Ethnicity | Oncogenic profile* | Oncogenic profile shared with tumor sample | Other mutations | Total # mutations | NGS used | Genomic references (PMID) | Genomic profiling | Comments | |||||||||
13 | MB2141 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | YES | not assigned | not assigned | Melanoma | Mucosal | subcutaneous metastasis | anorectal | Metastatic | Human | Female | 63 | Caucasian | EML4-ALK fusion | 29054983, 30185782 | See comments | Patient tumor has WES. PDX model has RNAseq. | Yes (Negative) | adherent | RPMI 1640, 10% FBS | Temperature: 37°C, 5% CO2 | 2 days | Liquid nitrogen | 90% FBS + 10% DMSO | ||||||
14 | MB3443 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | YES | N/A | N/A | Melanoma | Mucosal | subcutaneous neck metastais | vulvovaginal | Metastatic | Human | Female | 63 | Caucasian | NRAS Q61H, TSC2 A583T, RICTOR D1432N, CDKN2A loss | 29054983, 30185782 | RNAseq | Patient tumor has WES, Foundation Medicine testing. | |||||||||||||
15 | MB4628 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | YES | N/A | N/A | Melanoma | Mucosal | Primary nasopharyngeal | nasopharyngeal | Human | Male | 85 | Caucasian | NRAS Q61R | N/A | RNAseq | Unpublished. | ||||||||||||||
16 | MB4311 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | YES (Short-term culture) | N/A | N/A | Melanoma | Mucosal | Primary rectum | rectum | Human | Male | 60 | Caucasian | KRAS A146T, SF3B1 R625H, MYC amp, PTEN splice, ATM Q1765R, TSC1 H732Y, PMS2 H479Q | N/A (publication in progress) | RNAseq | Patient tumor has Foundation Medicine testing. | ||||||||||||||
17 | MB4103 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | NO | N/A | N/A | Melanoma | Mucosal | lymph node | anal canal | Lymph node metastasis | Human | Male | 41 | Caucasian | NRAS Q61R | N/A | RNAseq | Patient tumor has WES, Foundation Medicine testing. | |||||||||||||
18 | MB4079 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | NO | N/A | N/A | Melanoma | Mucosal | Primary Nasopharyngeal | nasopharyngeal | Human | Male | 75 | Caucasian | NRAS Q61H, GNAQ amp, GNAS S455P, PTEN loss, CDKN1A amp, CCND3 amp, JAK2 V617F, MAP3K1 S939C, PREX2 amp, PTCH1 FS, SPTA1 G66R | N/A | RNAseq | Patient tumor has WES, Foundation Medicine testing. | ||||||||||||||
19 | MB4414 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | NO | N/A | N/A | Melanoma | Mucosal | Primary rectum | rectum | Human | Male | 60 | Caucasian | NRAS G13D, NF1 W696fs*4, SF3B1 R625H | N/A | RNAseq | Patient tumor has Foundation Medicine testing. | ||||||||||||||
20 | MB3949 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | NO | N/A | N/A | Melanoma | Mucosal | Primary rectum | rectum | Human | Female | 57 | Caucasian | KIT L576P | N/A | RNAseq | Patient tumor has WES. | ||||||||||||||
21 | MB4723 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | NO | N/A | N/A | Melanoma | Mucosal | small bowel | vulvovaginal | Metastatic | Human | Female | 41 | Caucasian | NF1 L1305*, ATM rearr, CDK4 amp, CBL del ex8-9, TSC2 N958S, KDR amp, KIT amp, MDM2 amp | N/A | RNAseq | Patient tumor has Foundation Medicine testing. | |||||||||||||
22 | MB3532 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | NO | N/A | N/A | Melanoma | Mucosal | brain | vulvovaginal | Metastatic | Human | Female | 57 | Caucasian | Pan-negative, PTPN11 D425N | 30185782 | RNAseq | Patient tumor has Foundation Medicine testing. | |||||||||||||
23 | MB1816 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | NO | N/A | N/A | Melanoma | Mucosal | spleen | anorectal | Metastatic | Human | Female | 69 | Caucasian | Pan-negative | 29054983, 30185782 | RNASeq | Patient tumor has WES. | |||||||||||||
24 | MB2277 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | NO | N/A | N/A | Melanoma | Mucosal | primary left nasal sinusoid | left nasal sinusoid | Human | Female | 85 | Caucasian | Pan-negative, TSC1 N762S, KDR Rearr., B2M amp, CHD2 amp, IGF1R amp, IRF4 amp, IRS2 H29insN, MAP2K1 P15A | 29054983, 30185782 | RNAseq | Patient tumor has WES, Foundation Medicine testing. | ||||||||||||||
25 | MB4879 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | NO | N/A | N/A | Melanoma | Mucosal | groin lymph node | vagina/right clitoral bone | lymph node metastasis | Human | Female | 44 | Hispanic | BRAF wt. | N/A | N/A | Patient tumor has only had BRAF testing and was wild-type. | |||||||||||||
26 | MB5032 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | NO | N/A | N/A | Melanoma | Mucosal | primary right nasal cavity | right nasal cavity | Human | Male | 70 | Caucasian | BRAF wt, NRAS wt, KIT wt. | N/A | N/A | Patient tumor has only had BRAF, NRAS, and KIT testing and was wild-type. | ||||||||||||||
27 | MB1320 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | NO | N/A | N/A | Melanoma | Mucosal | lymph node | vulvovaginal | Lymph node metastasis | Human | Female | 41 | Caucasian | N/A | 29054983, 30185782 | RNAseq | Patient tumor has WES. | |||||||||||||
28 | MB4968 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | NO | N/A | N/A | Melanoma | Mucosal | inguinal lymph node | right lateral anal verge | Lymph node metastasis | Human | Male | 62 | Caucasian | N/A | N/A | N/A | Unpublished. | |||||||||||||
29 | MB5101 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | NO | N/A | N/A | Melanoma | Mucosal | inguinal lymph node | anal canal | Lymph node metastasis | Human | Male | 43 | Caucasian | NF1 splice 7458- 3_7501del47, KEL rearrangement intron 1, IGF1R amp | N/A | |||||||||||||||
30 | MB5205 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | NO | N/A | N/A | Melanoma | Mucosal | primary nasal | nasal | Human | Male | 66 | Caucasian | NF2 rearrangement intron 12, RAD21 amp, TP53 F270L | N/A | ||||||||||||||||
31 | MB5233 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | NO | N/A | N/A | Melanoma | Mucosal | axillary lymph node | right clitoral hone | axillary lymph node metastasis | Human | Female | 39 | Caucasian | NF1 splice 7458- 2A>G and KRAS amp, CCND1 amp, FGF19 amp, FGF3 amp, FGF4 amp, GNAS amp, NFKBIA amp | N/A | |||||||||||||||
32 | MB5384 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | NO | N/A | N/A | Melanoma | Mucosal | rectal | rectal | local metastasis | Human | Male | 73 | Caucasian | KIT K642E + NF1 V432fs*7, G842fs*23, TSC1 D998E, TSC2 A853T | N/A | |||||||||||||||
33 | MB5719 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | NO | N/A | N/A | Melanoma | Mucosal | primary rectal | rectal | local metastasis | Human | Male | 73 | Caucasian | KIT K642E + NF1 V432fs*7, G842fs*23, TSC1 D998E, TSC2 A853T | N/A | |||||||||||||||
34 | MB5867 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | NO | N/A | N/A | Melanoma | Mucosal | primary right paranasal sinus cavity | right paranasal sinus cavity | Human | Male | 74 | Caucasian | Unknown | N/A | ||||||||||||||||
35 | MB5994 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | NO | N/A | N/A | Melanoma | Mucosal | nasal primary | nasal | Human | Male | 78 | Caucasian | Unknown | N/A | ||||||||||||||||
36 | MB6115 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | NO | N/A | N/A | Melanoma | Mucosal | nasal primary | nasal | Human | Male | 79 | Caucasian | EGFR K852R | N/A | ||||||||||||||||
37 | MB6256 | Kasey Couts | University of Colorado | KASEY.COUTS@CUANSCHUTZ.EDU | NO | N/A | N/A | Melanoma | Mucosal | oral primary | oral | Human | Male | 71 | Caucasian | Unknown | N/A | ||||||||||||||||
38 | |||||||||||||||||||||||||||||||||
39 | |||||||||||||||||||||||||||||||||
40 | |||||||||||||||||||||||||||||||||
41 | |||||||||||||||||||||||||||||||||
42 | |||||||||||||||||||||||||||||||||
43 | |||||||||||||||||||||||||||||||||
44 | |||||||||||||||||||||||||||||||||
45 | |||||||||||||||||||||||||||||||||
46 | |||||||||||||||||||||||||||||||||
47 | |||||||||||||||||||||||||||||||||
48 | |||||||||||||||||||||||||||||||||
49 | |||||||||||||||||||||||||||||||||
50 | |||||||||||||||||||||||||||||||||
51 | |||||||||||||||||||||||||||||||||
52 | |||||||||||||||||||||||||||||||||
53 | |||||||||||||||||||||||||||||||||
54 | |||||||||||||||||||||||||||||||||
55 | |||||||||||||||||||||||||||||||||
56 | |||||||||||||||||||||||||||||||||
57 | |||||||||||||||||||||||||||||||||
58 | |||||||||||||||||||||||||||||||||
59 | |||||||||||||||||||||||||||||||||
60 | |||||||||||||||||||||||||||||||||
61 | |||||||||||||||||||||||||||||||||
62 | |||||||||||||||||||||||||||||||||
63 | |||||||||||||||||||||||||||||||||
64 | |||||||||||||||||||||||||||||||||
65 | |||||||||||||||||||||||||||||||||
66 | |||||||||||||||||||||||||||||||||
67 | |||||||||||||||||||||||||||||||||
68 | |||||||||||||||||||||||||||||||||
69 | |||||||||||||||||||||||||||||||||
70 | |||||||||||||||||||||||||||||||||
71 | |||||||||||||||||||||||||||||||||
72 | |||||||||||||||||||||||||||||||||
73 | |||||||||||||||||||||||||||||||||
74 | |||||||||||||||||||||||||||||||||
75 | |||||||||||||||||||||||||||||||||
76 | |||||||||||||||||||||||||||||||||
77 | |||||||||||||||||||||||||||||||||
78 | |||||||||||||||||||||||||||||||||
79 | |||||||||||||||||||||||||||||||||
80 | |||||||||||||||||||||||||||||||||
81 | |||||||||||||||||||||||||||||||||
82 | |||||||||||||||||||||||||||||||||
83 | |||||||||||||||||||||||||||||||||
84 | |||||||||||||||||||||||||||||||||
85 | |||||||||||||||||||||||||||||||||
86 | |||||||||||||||||||||||||||||||||
87 | |||||||||||||||||||||||||||||||||
88 | |||||||||||||||||||||||||||||||||
89 | |||||||||||||||||||||||||||||||||
90 | |||||||||||||||||||||||||||||||||
91 | |||||||||||||||||||||||||||||||||
92 | |||||||||||||||||||||||||||||||||
93 | |||||||||||||||||||||||||||||||||
94 | |||||||||||||||||||||||||||||||||
95 | |||||||||||||||||||||||||||||||||
96 | |||||||||||||||||||||||||||||||||
97 | |||||||||||||||||||||||||||||||||
98 | |||||||||||||||||||||||||||||||||
99 | |||||||||||||||||||||||||||||||||
100 |